2m 2m 2m 2m 2m 2m 2m
Viking Therapeut (VKTX)
NASDAQ
$27.67-$0.77 (-2.70%)
Price as of Nov 12, 2026 10:12 AM EST- $3.6BMarket Cap
- -30.26%1-Year Change
- BiotechnologyIndustry
Viking Therapeut (VKTX)
$27.67-$0.77 (-2.70%)
VKTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $28.44 | ||
Change | -$0.22 (-0.77%) | ||
Open | $28.69 | ||
High | $29.24 | ||
Low | $28.42 | ||
Previous Close | $28.66 | ||
Volume | 2,653,947 | ||
30-Day Average Volume | 4,391,337 | ||
1-Week Change | 1.68% | ||
1-Month Change | -0.25% | ||
1-Year Change | -30.26% | ||
3-Year Change | 190.80% | ||
5-Year Change | 355.77% | ||
Fundamentals | |||
Shares Outstanding | 127.5M | ||
Total Assets | $977.2M | ||
Market Cap | $3.6B | ||
Enterprise Value | $3.2B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$183.2M | ||
Free Cash Flow | -$138.2M | ||
EBIT | -$183.1M | ||
EBITDA | -$183.1M | ||
Net Working Capital | $839.1M | ||
EPS | -$1.55 | ||
Enterprise Value/EBITDA | -17 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 6 | ||
P/E | -18 | ||
PEG | 0 | ||
Price/Free Cash Flow | -26 | ||
Price/Operating Cash Flow | -26 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue